Research
Harvard Researchers Brace for Impact As NIH Threatens To Limit Support For Indirect Costs
In statements and interviews with The Crimson, nine life sciences researchers at Harvard said limits on indirect cost reimbursements would put critical research and administrative teams on the chopping block.
HMS Research Identifies Metabolic Enzyme That Facilitates Lung Cancer Growth
Researchers at the Harvard Medical School discovered that the enzyme GUK1 promotes lung cancer growth by boosting the metabolism of tumor cells, according to a Feb. 6 study published in Cell.
Harvard Researchers Discover Origin of Indo-European Language Family
Harvard researchers traced the origins of the vast Indo-European language family to the Caucasus-Lower Volga region, identifying the ancestral population that gave rise to more than 400 languages, in a study published on Feb. 5 in Nature journal.
Garber Blasts Trump’s Limits on NIH Support for Indirect Costs
Harvard President Alan M. Garber ’76 slammed the Trump administration’s Friday decision to limit National Institutes of Health funding for overhead costs associated with research projects in a Sunday afternoon email.
Harvard Study Finds Accreditation Reduces Jail Deaths by 93%
Accreditation of jail healthcare services may improve patient health and reduce jail deaths by 93 percent, according to a new Harvard study.
SEAS Professor Jennifer Lewis Awarded James Prize
The National Academy of Sciences awarded Harvard professor Jennifer A. Lewis the 2025 James Prize in Science and Technology Integration. Lewis’ work uses ink to 3D print biological materials such as human cells.
Harvard Begins Reviewing National Science Foundation Grants, Expanding Response to Trump’s Orders
Harvard Vice Provost for Research John H. Shaw sent an email Wednesday afternoon notifying faculty that the University would begin assessing National Science Foundation grants after the NSF instructed researchers to cease activities barred under President Donald Trump’s executive orders.
Harvard Schools Tell Researchers To Comply With Stop-Work Orders, Continue Other Federally Funded Projects
Research administrators at several of Harvard’s schools sent emails Tuesday afternoon urging faculty who received federal stop-work orders to comply, but to continue working on other federally sponsored projects as President Donald Trump’s federal funding freeze remains in limbo.
Federal Judge Temporarily Blocks Trump’s Funding Freeze
A federal U.S. district judge blocked President Donald Trump’s plan to pause funding for federal grants and loans just minutes before it was set to go into effect.
‘Opportunity to Experiment’: Visiting HBCU Scholars Praise Harvard’s Visiting Professorship Program
Four visiting professors from historically Black colleges and universities praised Harvard’s Faculty of Arts and Sciences Dean’s Visiting Professorship Program for offering the opportunity and funding to explore their scholarly work.
HMS Is Facing a Deficit. Under Trump, Some Fear It May Get Worse.
Harvard Medical School administrators and professors are already worried about the school’s tightening budget and declining federal research funds. Trump’s reelection adds a whole new level of risk.
HMS Study Reveals How Mutation Can Accelerate Breast Cancer Progression
A new study led by Harvard Medical School researchers shed new light on how even a single defective copy of the tumor-suppressor BRCA1 gene can increase patients’ risk of developing breast cancer.
HMS Study Suggests New Narratives for Pompeii Victims
New DNA analysis challenges existing hypotheses about the identities and relationships of victims found in Pompeii after the eruption of Mount Vesuvius in 79 C.E., per a study published in Current Biology on Nov. 7.
Pesticide Consumption May be Linked to Male Infertility, Harvard Study Suggests
A study conducted by the Harvard T.H. Chan School of Public Health demonstrated that high intake of pesticide residue from fruits and vegetables may reduce fertility in men.
HMS Study Sheds Light on Link Between Heart Condition and Cancer Treatment
A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition to continue immunotherapy treatment for the first time.